Literature DB >> 29748237

An Overview of PET Radiochemistry, Part 2: Radiometals.

Marie Brandt1,2, Jens Cardinale1,2, Margaret L Aulsebrook3, Gilles Gasser3, Thomas L Mindt4,2.   

Abstract

This continuing educational review provides an overview on radiometals used for PET. General aspects of radiometal-based radiotracers are covered, and the most frequently applied metallic PET radionuclides, 68Ga, 89Zr, and 64Cu, are highlighted with a discussion of their strengths and limitations.
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Keywords:  64Cu; 68Ga; 89Zr; metallic PET radionuclides; theranostics

Mesh：

Substances：

Year:  2018        PMID： 29748237     DOI： 10.2967/jnumed.117.190801

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  25 in total

Review 1.  A brief overview of metal complexes as nuclear imaging agents.

Authors:  Douglas S MacPherson; Kimberly Fung; Brendon E Cook; Lynn C Francesconi; Brian M Zeglis
Journal:  Dalton Trans       Date:  2019-10-07       Impact factor: 4.390

2.  CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging.

Authors:  Gary A Ulaner; Nicholas B Sobol; Joseph A O'Donoghue; Assen S Kirov; Christopher C Riedl; Ryan Min; Eric Smith; Lukas M Carter; Serge K Lyashchenko; Jason S Lewis; C Ola Landgren
Journal:  Radiology       Date:  2020-04-07       Impact factor: 11.105

Review 3.  A review of advances in the last decade on targeted cancer therapy using 177Lu: focusing on 177Lu produced by the direct neutron activation route.

Authors:  Rubel Chakravarty; Sudipta Chakraborty
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-12-15

Review 4.  Strained Ammonium Precursors for Radiofluorinations.

Authors:  Falco Reissig; Constantin Mamat
Journal:  ChemistryOpen       Date:  2022-06       Impact factor: 2.630

Review 5.  Perspectives on metals-based radioimmunotherapy (RIT): moving forward.

Authors:  Jordan M White; Freddy E Escorcia; Nerissa T Viola
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

6.  29th Annual GP2A Medicinal Chemistry Conference.

Authors:  Jean-Jacques Helesbeux; Laura Carro; Florence O McCarthy; Vânia M Moreira; Francesca Giuntini; Niamh O'Boyle; Susan E Matthews; Gülşah Bayraktar; Samuel Bertrand; Christophe Rochais; Pascal Marchand
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-07

Review 7.  Artificial Intelligence and the Future of Diagnostic and Therapeutic Radiopharmaceutical Development:: In Silico Smart Molecular Design.

Authors:  Bahar Ataeinia; Pedram Heidari
Journal:  PET Clin       Date:  2021-08-05

8.  Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of 99mTc-Tricarbonyl-Based Radiopharmaceuticals.

Authors:  Carolina Giammei; Theresa Balber; Katarina Benčurová; Jens Cardinale; Neydher Berroterán-Infante; Marie Brandt; Nedra Jouini; Marcus Hacker; Markus Mitterhauser; Thomas L Mindt
Journal:  Molecules       Date:  2020-06-09       Impact factor: 4.411

9.  Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4.

Authors:  Simon A M Kaeppeli; Roger Schibli; Thomas L Mindt; Martin Behe
Journal:  EJNMMI Radiopharm Chem       Date:  2019-05-16

10.  Automated preparation of clinical grade [68Ga]Ga-DOTA-CP04, a cholecystokinin-2 receptor agonist, using iPHASE MultiSyn synthesis platform.

Authors:  Mohammad B Haskali; Peter D Roselt; David Binns; Amit Hetsron; Stan Poniger; Craig A Hutton; Rodney J Hicks
Journal:  EJNMMI Radiopharm Chem       Date:  2019-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.